GLP Claro › VIV RX

VIV RX — prices and signals

FDA letter

Per a third-party source cited by GLP Claro on 2026-10-17, VIV RX's lowest published all-in monthly price is $199 for compounded injectable semaglutide (source). FDA sent it a warning letter on 2026-02-20 (letter); confirm the price with the clinic; not medical advice.

Clinic website ↗Checked: 2026-10-17

FDA warning letter (2026-02-20). FDA sent this company a letter about how it promoted drugs. It may have been corrected since. Read the letter ↗

Semaglutide (injection) Compounded

Published regular price$199 /mo
Intro price—
Mandatory membership$0
Price by doseSame price at every dose (per source)
All-in per month*$199
6-month estimate*$1,194 (estimate, not a quote)
SourceThird-party figure: https://allglp1.com/glp1-daily-price-tracker
All-inclusive price (med + visit + labs)To be verified
Chemical formTo be verified
Pen or vialTo be verified
NotesNo confirmado en la página de la clínica el 17 oct 2026.

Tirzepatide (injection) Compounded

Published regular price$279 /mo
Intro price—
Mandatory membership$0
Price by doseSame price at every dose (per source)
All-in per month*$279
6-month estimate*$1,674 (estimate, not a quote)
SourceThird-party figure: https://allglp1.com/glp1-daily-price-tracker
All-inclusive price (med + visit + labs)To be verified
Chemical formTo be verified
Pen or vialTo be verified
NotesNo confirmado en la página de la clínica el 17 oct 2026.

* All-in/mo and the 6-month estimate are GLP Claro calculations from published prices. They exclude taxes, labs and special shipping. If price rises with dose, we show a range between the lowest and highest published price. Not medical advice or a dosing recommendation.

Not medical advice. Compounded drugs are not FDA-approved and are not the same as brand-name drugs. Talk to a licensed clinician.